Integrated Diagnostics Holdings

IDHCHealthcare
0.3440USD
2.08%
Market Cap
199.98M
Volume
930
0% of avg
P/E Ratio
0.19
EPS (TTM)
1.77
Beta
0.23
Day Range
0.3240p - 0.3400p
52 Week Range
0.2750p0.3440p0.5400p
0.3440p

Upcoming Events

Mid-August 2025
Release of half-year 2025 results
High Impact Event
Early Q1 2026
Full year 2025 results announcement
High Impact Event
IDHC
NEUTRAL

IDH Expands Radiology Portfolio with Radiotherapy Acquisition

The healthcare diagnostics provider has acquired a radiology and radiotherapy facility in Cairo, Egypt, expanding its radiology portfolio in the country.

IDHC
VERY GOOD

Integrated Diagnostics Holdings Kicks Off 2025 with Strong Q1 Results

The diagnostics provider reported a 35% jump in revenue and substantial margin expansion in Q1 2025, signaling a strong start to the year.

IDHC
NEUTRAL

Integrated Diagnostics Holdings Provides General Update

The healthcare provider offers a general update on its operations across the Middle East and Africa.

IDHC
NEUTRAL

Integrated Diagnostics Holdings Publishes 2024 Annual Report and Announces AGM

The healthcare diagnostics company has published its 2024 annual report and announced the date for its upcoming annual general meeting.

IDHC
GOOD

IDH Reports Strong 39% Revenue Growth and 115% Profit Surge in 2024 Results

The diagnostics services provider reported a 39% revenue surge and 115% profit increase, driven by higher test volumes and improved margins. Despite strong performance, the company faces challenges in certain markets and economic uncertainties.

IDHC
NEUTRAL

Integrated Diagnostics Holdings Provides General Update

The healthcare company provides a general update on its operations in the Middle East and Africa.

IDHC
GOOD

IDH Expands Footprint in Saudi Arabia with Increased Stake in Biolab KSA

The healthcare provider is expanding its presence in Saudi Arabia by increasing its stake in a local subsidiary, signaling confidence in the market's growth potential.

IDHC
GOOD

Integrated Diagnostics Holdings Reports Robust 9M 2024 Results

The diagnostics provider reported robust 9M 2024 results, with double-digit growth in revenue and profitability. Expansion into Saudi Arabia progressing well, though challenges persist in Nigeria and Sudan.

IDHC
NEUTRAL

Integrated Diagnostics Holdings Announces Upcoming Results Release

Diagnostics company announces upcoming results release, generating anticipation among investors.

IDHC
NEUTRAL

Integrated Diagnostics Delays Treasury Shares Removal

Healthcare diagnostics company provides update on administrative process